Log in to your IBTimes Account

close
ID
Password
  • Set your IBTimes.com Edition

Salix Asks FDA to Review Colitis Drug



By AP
31 December 2007 @ 11:40 am ET

RALEIGH, N.C. - Salix Pharmaceuticals Ltd. said Monday it submitted an application to the Food and Drug Administration for marketing approval of its product granulated mesalamine to treat a type of colitis.

Related Topic

Get stories by e-mail on this topic.

E-mail:
Quotes
SLXP 9.79 -0.06

The stock fell sharply to a new four-year low Monday after Wall Street learned the drug developer's key product Colazal, also for ulcerative colitis, faces generic competition from three companies.

Salix's new drug application seeks approval for once-a-day dosing of granulated mesalamine to help patients stay in remission from ulcerative colitis. The disease causes ulcers in the lining of the rectum and colon.

The Raleigh, N.C.-based company believes the application will be subject to a 10-month review period by the FDA.

The application is based on results from two studies that showed a statistically significantly greater proportion of patients on granulated mesalamine stayed in remission.

Salix said ulcerative colitis patients dosed once a day with 1.5 grams of the drug remained relapse-free over six months of treatment compared with patients on placebo.

Salix acquired rights to market granulated mesalamine in the U.S. from Dr. Falk Pharma GmbH of Germany. Dr. Falk Pharma sells granulated mesalamine in Germany and other European countries, as well as Australia, under the trade name Salofalk Granu-Stix.

Salix's stock dropped $1.36, or 15.1 percent, to $7.66 in very heavy morning trade, having fallen to a new 52-week low of $7.50 earlier in the day. That's the stock's lowest level since August 2003. Previously, the stock traded between $8.78 and $16.38 over the past 52 weeks.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name


advertisement
More Industries
China's ambitious plan to increase wind power capacity could attract up to $150 billion in investment, but Beijing will have to get serious about revampi...
Top oil and gas firm PetroChina raised daily output at its largest Sulige gasfield, in northern China's Ordos Basin, to 25.6 million cubic metres, up 67 ...
Volkswagen chief executive Martin Winterkorn said Europe's largest auto maker sold 6 percent more cars and transporters in June than in the same month a ...

Advertisement
Forex trading is too complicated?

Can predict currency pairs movements? Binary option trading is what you need. Click here.

70% Profit in Less Than an Hour

Take profit from the markets roller coaster. No downloads, no commissions, no spreads.

Press Release Distribution - IBwire

Effective and Affordable Press Release Distribution Service

advertisement
 
IBTimes.com Web
Partners
International Business Times© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives